Cargando…

AA Amyloidosis in a patient with glycogen storage disorder and progressive chronic kidney disease

Type 1 glycogen storage diseases (GSD) are inherited metabolic diseases caused by defects in the activity of the glucose-6-phosphate transporter. We present the case of a 40-year-old male with glycogen storage disease type 1b (GSD1b) who was referred to our nephrology service for evaluation of his c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dick, Jonathan, Kumar, Nicola, Horsfield, Catherine, Jayawardene, Satish
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2012
Materias:	Original Contributions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4400565/ https://www.ncbi.nlm.nih.gov/pubmed/26069801 http://dx.doi.org/10.1093/ckj/sfs143

Ejemplares similares

AA amyloidosis in the renal allograft: a report of two cases and review of the literature
por: Rojas, Rebecca, et al.
Publicado: (2012)

Post COVID-19 AA amyloidosis of the kidneys with rapidly progressive renal failure
por: Mir, Tajamul H., et al.
Publicado: (2023)

Desmopressin use prior to renal transplant biopsy—does it fit?
por: Anandagoda, Nelomi, et al.
Publicado: (2014)

Kidney dysfunction due to AA amyloidosis in a morbidly obese female
por: Izzedine, Hassan, et al.
Publicado: (2023)

AA amyloidosis and pyrin gene mutations
por: Konstantopoulos, K., et al.
Publicado: (2005)

AA Amyloidosis Presenting as Crescentic Glomerulonephritis
por: Etta, Praveen K., et al.
Publicado: (2020)

Chronic brucellosis with hepatic brucelloma and AA amyloidosis in a patient with autosomal dominant polycystic kidney disease
por: Kollabathula, Arpitha, et al.
Publicado: (2019)

AA-amyloidosis in a kidney biopsy on top of pauci-immune crescentic glomerulonephritis
por: Neild, G. H., et al.
Publicado: (2012)

Cancer-Associated AA Amyloidosis Presenting as Crescentic Glomerulonephritis
por: Zuckerman, Jonathan E., et al.
Publicado: (2019)

Unusual Combination of Tracheobronchopathia Osteochondroplastica and AA Amyloidosis
por: Kırbaş, Gökhan, et al.
Publicado: (2009)

OR14-001 – Tocilizumab in autoinflammation and AA amyloidosis
por: Lane, T, et al.
Publicado: (2013)

Systemic AA amyloidosis: epidemiology, diagnosis, and management
por: Real de Asúa, Diego, et al.
Publicado: (2014)

Recent Insights into the Pathogenesis of Type AA Amyloidosis
por: van der Hilst, J. C. H.
Publicado: (2011)

Inhibitory effect of propolis on the development of AA amyloidosis
por: Harata, Daichi, et al.
Publicado: (2017)

Oxazolone-induced gastrointestinal disorders enhance the oral transmission of AA amyloidosis in mice
por: KOBAYASHI, Hiroto, et al.
Publicado: (2021)

AA-Amyloidosis Can Be Transferred by Peripheral Blood Monocytes
por: Sponarova, Jana, et al.
Publicado: (2008)

Review of eprodisate for the treatment of renal disease in AA amyloidosis
por: Rumjon, Adam, et al.
Publicado: (2012)

AA amyloidosis in a patient with Langerhans cell histiocytosis
por: Thomson, Peter C., et al.
Publicado: (2011)

Renal parenchymal calcification secondary to systemic AA amyloidosis
por: Burton, Hannah M.M., et al.
Publicado: (2014)

Empirical use of anakinra in AA amyloidosis of uncertain aetiology
por: Lane, T, et al.
Publicado: (2015)

Gout and AA-Amyloidosis: A Case-Based Review
por: Gromova, Margarita Aleksandrovna, et al.
Publicado: (2021)

AA-amyloidosis in cats (Felis catus) housed in shelters
por: Ferri, Filippo, et al.
Publicado: (2023)

Assessment of Mean Platelet Volume in Patients with AA Amyloidosis and AA Amyloidosis Secondary to Familial Mediterranean Fever: A Retrospective Chart – Review Study
por: Bakan, Ali, et al.
Publicado: (2019)

Rapid progression of aortic and mitral stenosis in a patient with AA amyloidosis: a case report
por: Frumkin, David, et al.
Publicado: (2019)

Kidney and Metabolic Phenotypes in Glycogen Storage Disease Type-I Patients
por: Aoun, Bilal, et al.
Publicado: (2020)

Glycogen storage diseases: An update
por: Gümüş, Ersin, et al.
Publicado: (2023)

P02-019 - Detection of risk factors for AA-amyloidosis
por: Németh, S, et al.
Publicado: (2013)

Renal AA Amyloidosis in Patients with Type 2 Diabetes Mellitus
por: Díez, Ramón, et al.
Publicado: (2014)

Educational Case: AA Amyloidosis Complicating Common Variable Immunodeficiency
por: Kapp, Meghan E., et al.
Publicado: (2021)

Alleviation of a polyglucosan storage disorder by enhancement of autophagic glycogen catabolism
por: Kakhlon, Or, et al.
Publicado: (2021)

Role of Astrocytes in the Pathophysiology of Lafora Disease and Other Glycogen Storage Disorders
por: Duran, Jordi
Publicado: (2023)

Next-generation glycogen storage diseases
por: Derks, Terry G. J., et al.
Publicado: (2018)

Biomarkers in Glycogen Storage Diseases: An Update
por: Molares-Vila, Alberto, et al.
Publicado: (2021)

Molecular and clinical profiling in a large cohort of Asian Indians with glycogen storage disorders
por: Kumar, Tejashwini Vittal, et al.
Publicado: (2022)

Churg-Strauss syndrome associated with AA amyloidosis: a case report
por: Maamar, Mouna, et al.
Publicado: (2012)

Oral involvement in a case of AA amyloidosis: a case report
por: Cengiz, M İnanç, et al.
Publicado: (2010)

PW03-029 – Risk factors for AA-type amyloidosis in Germany
por: Blank, N, et al.
Publicado: (2013)

Variegate porphyria complicated by systemic AA amyloidosis: a case report
por: Tsuchiya, Yoshiki, et al.
Publicado: (2013)

A Rare Case of Renal AA Amyloidosis Secondary to Sjogren’s Syndrome
por: Costa, Mylene, et al.
Publicado: (2019)

Amyloid fibril structure from the vascular variant of systemic AA amyloidosis
por: Banerjee, Sambhasan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gh61uh8f7vcri0t37lnn44a177